Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study

Abstract

In this prospective cohort, serum biomarkers of biochemical disease were effective in short-term prediction of preeclampsia, and the performance of GlyFn in particular as a POC test may meet the needs of rapid and accurate triage and intervention.